High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial — Christos Papadimitriou (2007) | RDL Network
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial
Sergio Giralt, D. Weber, M I Colome, Meletios A Dimopoulos, Rakesh Mehra, Koen van Besien, James Gajewski, Börje S. Andersson, Issa F. Khouri, Donna Przepiorka, B von Wolff, Kay Delasalle, M Körbling, David Seong, Raymond Alexanian, Richard E. Champlin
Discussion(0)
No comments yet. Be the first to comment.